Nektar Small Molecule PEGylation programs highlighted in the March 2008 issue of R&D Directions.
more
May 7, 2008 Q1 2008 Nektar Therapeutics Financial Results Conference Call Listen to Webcast
April 14, 2008Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting April 10, 2008Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
Cimzia® approved in the U.S. for Crohn’s Disease more
NKTR-061 (inhaled amikacin) for gram-negative pneumonias more
Listen to Webcast
